KWS BioTest is an established preclinical contract research organisation that brings together internationally renowned scientific expertise in a commercially managed environment for the preclinical efficacy testing of prophylactic and therapeutic agents as treatments for human diseases.
Formed in 2004, KWS BioTest originates from the University of Bristol, and operates in state of the art facilities focused on contract research. The ability to bring academic expertise into a dedicated contract research environment allows KWS BioTest to provide an unrivalled expertise in preclinical efficacy testing, pharmacology and drug development.
The company has grown year on year since forming in order to serve an ever increasing list of clients, most of whom have come back for further work. Since beginning as a specialist in autoimmunity and infection, KWS has expanded its offering to provide a wide range of assays and models in areas spanning inflammation, allergy, neurodegenerative disease, pain, proteomics and protein biochemistry. KWS BioTest invests in an extensive research and development pipeline with the aim of innovating and validating new services and models.
KWS BioTest continues to recognise the importance of specific development objectives and is committed to working closely with clients to design and implement cost-effective drug development programmes starting in early lead identification and spanning the research and development process into the clinic. In essence, KWS seeks to provide its clients with a flexible, forward thinking partner willing to think through the individual needs of a programme rather than just a faceless organisation able to follow client produced protocols.
All work performed by KWS BioTest continues to be guided by the principles of the 3Rs and is conducted to the highest standards of welfare. The quality of experiments is controlled and assured through the application of a rigorous quality procedure. This includes regular external audit to ensure that the laboratory is working according to the principles of GLP.